Clinical Trial Update: Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2a clinical trial update for DTA-H19 in advanced ovarian cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• DTA-H19

Snippet

Sponsor: Anchiano Therapeutics Israel Ltd. | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-13